F-star Biotechnology
Latest round
- Series A
Last raised
- Oct 2013
Total raised
- $35M
Investors
- 7
About F-star Biotechnology
F-star Biotechnology Limited specializes in the development of multispecific antibody therapeutics.00 mn. Prior to this acquisition, F-star had completed 9 deals, marking its impactful presence in the biotechnology sector.F-star Therapeutics Ltd. specializes in the development of next-generation multispecific antibody therapeutics, particularly focusing on its proprietary tetravalent bispecific antibody format. This innovative approach allows for the simultaneous targeting of multiple antigens, enhancing the activation of the immune system in patients suffering from cancer and other serious diseases. The company’s advanced pipeline includes first-in-class and best-in-class drug candidates designed to collaborate with a patient's immune system, targeting hard-to-treat cancers to improve patient quality of life and longevity.F-star Therapeutics Ltd.87 mn. The company generates revenue through partnerships and collaborations with pharmaceutical companies and research institutions, focusing on the development and commercialization of its bispecific antibody therapeutics. Its transaction structures typically involve strategic alliances including licensing agreements and co-development partnerships, allowing for shared risks and resources in drug development.00 mn, a transaction completed in March 2023. This acquisition will support the development of Sino Biopharm’s International Biopharmaceutical R&D Platform, facilitating F-star’s future expansions. The company aims to leverage its innovative bispecific antibody therapeutics to penetrate new markets, particularly focusing on increasing access to therapies in Asia while also consolidating its presence in North America and Europe.
Who invested in F-star Biotechnology
7 investors across 5 rounds
See all investors in F-star Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about F-star Biotechnology
Who invested in F-star Biotechnology?
F-star Biotechnology has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has F-star Biotechnology raised?
F-star Biotechnology has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did F-star Biotechnology last raise money?
F-star Biotechnology's most recent round on record is a Series A, in Oct 2013.
What does F-star Biotechnology do?
F-star Biotechnology Limited specializes in the development of multispecific antibody therapeutics.
Where is F-star Biotechnology headquartered?
F-star Biotechnology is headquartered in Cambridge, UK.
Which VCs invest in companies like F-star Biotechnology?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at F-star Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like F-star Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.